%D8%A5%D8%B9%D8%A7%D8%AF%D8%A9_%D8%AA%D9%88%D8%B6%D9%8A%D8%B9_%D8%A7%D9%84%D8%AF%D9%88%D8%A7%D8%A1%CE%95%CF%80%CE%B1%CE%BD%CE%B1%CF%83%CF%84%CF%8C%CF%87%CE%B5%CF%85%CF%83%CE%B7_%CF%86%CE%B1%CF%81%CE%BC%CE%AC%CE%BA%CF%89%CE%BDDrug_repositioningReposicionamiento_de_medicamentosRepositionnement_des_m%C3%A9dicaments%E3%83%89%E3%83%A9%E3%83%83%E3%82%B0%E3%83%AA%E3%83%9D%E3%82%B8%E3%82%B7%E3%83%A7%E3%83%8B%E3%83%B3%E3%82%B0Q5308921
about
P1269
'RE:fine drugs': an interactive dashboard to access drug repurposing opportunitiesValidating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortalityThe clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replicationNetwork-based in silico drug efficacy screeningThe Drug Repurposing Hub: a next-generation drug library and information resourceDrug repositioning: a machine-learning approach through data integration.RepTB: a gene ontology based drug repurposing approach for tuberculosis.A systematic approach for identifying shared mechanisms in epilepsy and its comorbiditiesThe ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosisSemantic Knowledge Graph Network Features for Drug RepurposingIdentifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug DesignSelecting precise reference normal tissue samples for cancer research using a deep learning approachConserved Disease Modules Extracted From Multilayer Heterogeneous Disease and Gene Networks for Understanding Disease Mechanisms and Predicting Disease TreatmentsIdentification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology AnalysisDrug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived EnemyTransthyretin stabilization activity of the catechol--methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept studyEntry Into New Therapeutic Areas: The Effect of Alliance on Clinical TrialsTrends of Clinical Trials for Drug Development in Rare DiseasesRepurposing drugs to target nonalcoholic steatohepatitisComputational Prediction of Drug-Target Interactions via Ensemble LearningA Comparative Study of Cluster Detection Algorithms in Protein-Protein Interaction for Drug Target Discovery and Drug RepurposingDrug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic CancersMulti-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast CancerDrug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate AirwaysDrug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancerPotential for Drug Repositioning of Midazolam for Dentin RegenerationPS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signaturesIdentifying Drug Repositioning Candidates using Comparative Mechanism Enrichment in Neurodegenerative DiseasesIdentifying Drug Repositioning Candidates using Representation Learning on Heterogeneous NetworksThe Human Brain Pharmacome: An Overview
P921
Q24745976-7802609b-4515-6015-99c1-a00d729eb4a1Q24745996-d46b1e00-44fc-fcec-a4e9-f3d6be93d7bbQ25707196-f529fa6e-4df8-6f26-f326-c237ee75abd8Q28601372-0d53ff6c-4118-cb70-bac0-3bbf2442fdd2Q29363901-8e184e6e-4d9b-4b39-fbf3-a390a9512d67Q30651571-f7bcaa7e-4678-ee62-2c9e-1ff27ef7b856Q54203363-0134726a-4643-a69a-8d24-19639e6a7052Q54243730-f295f067-4f5d-d697-32e4-542f7f5ffe1eQ57041198-40A119ED-3922-413D-9E08-D2D5C4630863Q58880279-f6a31424-4458-de60-9248-f8e59c268027Q61451256-C83454E7-6A4F-4A2F-A1CC-5CBF3C06F9FDQ61804793-17B37AB0-0720-4D58-8338-CDD160CCC7BEQ61813251-E1744E3E-CECE-46C6-B89B-F8A6A9E068DBQ61814553-120E512A-9A4B-4375-8BB7-4D8EF60F7844Q63246314-A2626BFF-21DF-46A2-AB2B-14BF1EF25FE2Q64039242-600C1EFE-841B-4BA6-9445-05B6D8139DABQ64042713-C3E173C9-40A5-4DA5-AD0A-6EB1E55C625AQ64045177-4E332B46-972F-4455-9FE6-6A77093C6901Q64099909-D9073991-058A-4495-89B8-EFF11A765A1CQ64119813-CD4A4146-3C30-4711-AE36-81EFA32D409DQ64228694-466BB419-1DBA-47D1-AC29-35EA1BFE8356Q64238344-D1912AF6-A0BE-4993-9651-89B75407AA11Q64249080-ADC26966-9FD6-4671-914F-7447351B4834Q64262760-5EDC29E4-466E-49F9-B396-15C1D6395797Q64272815-87CA6308-897E-458A-A051-B2AFF0C5C14FQ64276210-2DEAD05B-6697-43C4-BE33-432014152921Q66968371-4db76473-49a8-5943-d47f-90954eb48f7dQ70206849-0fd05f66-435c-4b6f-20a0-4283db17087bQ70206904-3fe720d5-40c4-5fc9-6385-a68e38a8edd6Q70206943-eeb7a385-4027-d48b-391b-82ac049707b3
P921
description
subfield of pharmacology
@en
مجالٌ فرعي في علم الصيدلة
@ar
name
Reposicionamiento de medicamentos
@es
Repositionnement des médicaments
@fr
drug repositioning
@en
recelado de medikamento
@eo
Επαναστόχευση φαρμάκων
@el
إعادة توضيع الدواء
@ar
ドラッグリポジショニング
@ja
药物重定位
@zh
type
label
Reposicionamiento de medicamentos
@es
Repositionnement des médicaments
@fr
drug repositioning
@en
recelado de medikamento
@eo
Επαναστόχευση φαρμάκων
@el
إعادة توضيع الدواء
@ar
ドラッグリポジショニング
@ja
药物重定位
@zh
altLabel
drug re-profiling
@en
drug re-tasking
@en
drug repurposing
@en
re-profiling
@en
re-tasking
@en
therapeutic switching
@en
Επαναστόχευση Φαρμάκων
@el
إعادة استخدام الدواء
@ar
إعادة تحديد غرض الدواء
@ar
توضعة الدواء
@ar
prefLabel
Reposicionamiento de medicamentos
@es
Repositionnement des médicaments
@fr
drug repositioning
@en
recelado de medikamento
@eo
Επαναστόχευση φαρμάκων
@el
إعادة توضيع الدواء
@ar
ドラッグリポジショニング
@ja
药物重定位
@zh
P486
P6366
P1889
P3417
Drug-Repositioning